Skip to content

Evaluation of the stability of short implants in the posterior maxilla and the posterior mandible using the Periotest: controlled clinical trial

Evaluation of the stability of short implants in the posterior maxilla and the posterior mandible using the Periotest: controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201610001197438
Enrollment
30
Registered
2015-07-11
Start date
2014-11-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral Health atrophic posterior maxilla and mandible

Interventions

short implant placement in atrophic posterior maxilla
short implant placement in atrophic posterior mandible

Sponsors

Faculty of Oral and Dental Medicine, Cairo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Any partially edentulous patient missing teeth in the posterior area requiring 1 to 2 dental implants. 2. Patient age: 18 years or older 3. Able to sign an informed consent form. 4. Patients with no systemic diseases. 5. Patients who are cooperative, motivated, and hygiene conscious. 6. The recipient site of the implant should be free from any pathological conditions. 7. Vertical bone heights at implant sites have to be 8.5 - 10 mm above the mandibular canals and 7.5 - 9 mm below the maxillary sinuses. 8. Bone thickness has to be at least 6 mm.

Exclusion criteria

Exclusion criteria: 1. Systemic contraindications to implant surgery 2. Patients in the growth stage with partially erupted teeth 3. Patient subjected to irradiation in the head and neck area 4. Immunosuppressed or immunocompromised 5. Patient treated or under treatment with intravenous amino-bisphosphonates 6. Patients with untreated periodontitis 7. Patients with poor oral hygiene and motivation 8. Uncontrolled diabetes and heavy smokers 9. Pregnant or nursing 10.Substance abuse 11. Psychiatric problems or unrealistic expectations 12. Lack of opposite occluding dentition in the area intended for implant placement 13.Acute or chronic infection/inflammation in the area intended for implant placement

Design outcomes

Primary

MeasureTime frame
stability of the implants using Periotest

Secondary

MeasureTime frame
marginal bone level around implants using CBVT

Countries

Egypt

Contacts

Public Contactahmed reda

assistant professor

dr.a.reda@gmail.com00201006608568

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026